HEART failure with preserved ejection fraction (HFpEF) is present in 74% of patients with severe isolated secondary tricuspid ...

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement ...

For patients with symptomatic and severe tricuspid regurgitation (TR), tricuspid transcatheter edge-to-edge repair (T-TEER) ...

Transcatheter tricuspid-valve replacement is superior to medical therapy alone for patients with severe tricuspid regur ...

"We are excited to work with the leading heart valve centers in the U.S. to offer more patients suffering from tricuspid regurgitation a treatment option. The initiation of the TANDEM II Early ...

Background: Despite progressively high morbidity and mortality rates associated with severe tricuspid regurgitation (TR), limited treatment options are available. Aims: The single-arm, multicenter, ...

Even though it has been consistently demonstrated that severe tricuspid regurgitation (TR) is linked to a worse prognosis and a higher death rate, it is still undertreated and treated conservatively.

Background– Prognostically-meaningful tricuspid regurgitation (TR) surrounding transcatheter edge-to-edge repair (TEER) for mitral regurgitation (MR) is ill-defined. Objective– To explore the ...

TUESDAY, Nov. 5, 2024 (HealthDay News) — For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical therapy ...